Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide
- PMID: 25784704
- PMCID: PMC4453578
- DOI: 10.1128/mBio.02481-14
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide
Abstract
Choline is a water-soluble nutrient essential for human life. Gut microbial metabolism of choline results in the production of trimethylamine (TMA), which upon absorption by the host is converted in the liver to trimethylamine-N-oxide (TMAO). Recent studies revealed that TMAO exacerbates atherosclerosis in mice and positively correlates with the severity of this disease in humans. However, which microbes contribute to TMA production in the human gut, the extent to which host factors (e.g., genotype) and diet affect TMA production and colonization of these microbes, and the effects TMA-producing microbes have on the bioavailability of dietary choline remain largely unknown. We screened a collection of 79 sequenced human intestinal isolates encompassing the major phyla found in the human gut and identified nine strains capable of producing TMA from choline in vitro. Gnotobiotic mouse studies showed that TMAO accumulates in the serum of animals colonized with TMA-producing species, but not in the serum of animals colonized with intestinal isolates that do not generate TMA from choline in vitro. Remarkably, low levels of colonization by TMA-producing bacteria significantly reduced choline levels available to the host. This effect was more pronounced as the abundance of TMA-producing bacteria increased. Our findings provide a framework for designing strategies aimed at changing the representation or activity of TMA-producing bacteria in the human gut and suggest that the TMA-producing status of the gut microbiota should be considered when making recommendations about choline intake requirements for humans.
Importance: Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, and increased trimethylamine N-oxide (TMAO) levels have been causally linked with CVD development. This work identifies members of the human gut microbiota responsible for both the accumulation of trimethylamine (TMA), the precursor of the proatherogenic compound TMAO, and subsequent decreased choline bioavailability to the host. Understanding how to manipulate the representation and function of choline-consuming, TMA-producing species in the intestinal microbiota could potentially lead to novel means for preventing or treating atherosclerosis and choline deficiency-associated diseases.
Copyright © 2015 Romano et al.
Figures




Similar articles
-
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.Nutrients. 2020 Aug 5;12(8):2340. doi: 10.3390/nu12082340. Nutrients. 2020. PMID: 32764281 Free PMC article. Review.
-
Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.J Pharm Biomed Anal. 2018 Sep 10;159:100-112. doi: 10.1016/j.jpba.2018.06.027. Epub 2018 Jun 28. J Pharm Biomed Anal. 2018. PMID: 29980011
-
Transmission of atherosclerosis susceptibility with gut microbial transplantation.J Biol Chem. 2015 Feb 27;290(9):5647-60. doi: 10.1074/jbc.M114.618249. Epub 2014 Dec 30. J Biol Chem. 2015. PMID: 25550161 Free PMC article.
-
Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality.Nutr Diabetes. 2021 Jul 31;11(1):27. doi: 10.1038/s41387-021-00169-w. Nutr Diabetes. 2021. PMID: 34389700 Free PMC article.
-
Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.Annu Rev Nutr. 2017 Aug 21;37:157-181. doi: 10.1146/annurev-nutr-071816-064732. Epub 2017 Jul 17. Annu Rev Nutr. 2017. PMID: 28715991 Review.
Cited by
-
Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review.Int J Mol Sci. 2020 Aug 20;21(17):5999. doi: 10.3390/ijms21175999. Int J Mol Sci. 2020. PMID: 32825440 Free PMC article. Review.
-
Dietary Components, Microbial Metabolites and Human Health: Reading between the Lines.Foods. 2020 Aug 3;9(8):1045. doi: 10.3390/foods9081045. Foods. 2020. PMID: 32756378 Free PMC article. Review.
-
Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis.BMJ Open Diabetes Res Care. 2019 Nov 15;7(1):e000718. doi: 10.1136/bmjdrc-2019-000718. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 31798892 Free PMC article. Clinical Trial.
-
Immune mechanism of gut microbiota and its metabolites in the occurrence and development of cardiovascular diseases.Front Microbiol. 2022 Dec 14;13:1034537. doi: 10.3389/fmicb.2022.1034537. eCollection 2022. Front Microbiol. 2022. PMID: 36590426 Free PMC article. Review.
-
A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects.Nutrients. 2021 Oct 17;13(10):3637. doi: 10.3390/nu13103637. Nutrients. 2021. PMID: 34684638 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases